EVIDENTIS Trademark

Trademark Overview

On Friday, July 11, 2025, a trademark application was filed for EVIDENTIS with the United States Patent and Trademark Office. The USPTO has given the EVIDENTIS trademark a serial number of 99279248. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, July 11, 2025. This trademark is owned by Evidentis Clinical Research, PLLC. The EVIDENTIS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Medical and scientific research, namely, conducting clinical trials for others
evidentis

General Information

Serial Number99279248
Word MarkEVIDENTIS
Filing DateFriday, July 11, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateFriday, July 11, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesProviding medical and scientific research information in the field of pharmaceuticals and clinical trials; Medical and scientific research, namely, conducting clinical trials for others

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, July 11, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEvidentis Clinical Research, PLLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSouthlake, TX 76092

Trademark Events

Event DateEvent Description
Friday, July 11, 2025NEW APPLICATION ENTERED
Friday, July 11, 2025APPLICATION FILING RECEIPT MAILED

Related Keywords

evidentis clinical trials research scientific medical namely conducting others field information